{
  "question_stem": {
    "en": "An 82-year-old man is brought to the emergency department after a syncopal episode. He has had no chest pain or dyspnea but he has constipation of recent onset. He was hospitalized 2 weeks ago for atrial fibrillation with rapid ventricular response and was discharged home with oral medications after appropriate management. Medical history is also significant for hypertension and severe chronic obstructive pulmonary disease requiring home supplemental oxygen. Blood pressure is 105/60 mm Hg and pulse is 50/min. Examination reveals bilaterally decreased breath sounds, no wheezing, and normal heart sounds. ECG shows new-onset second-degree atrioventricular block.",
    "zh": "一名82岁男性在发生晕厥发作后被送往急诊科。他没有胸痛或呼吸困难，但最近出现了便秘。他于2周前因快速心室反应的房颤住院，在适当的治疗后出院并口服药物。病史还包括高血压和需要家庭补充氧气的严重慢性阻塞性肺病。血压为105/60 mmHg，脉搏为50次/分钟。检查显示双侧呼吸音减弱，无喘息，心脏听诊正常。心电图显示新发二度房室传导阻滞。"
  },
  "question": {
    "en": "Which of the following drugs is the most likely cause of his current condition?",
    "zh": "以下哪种药物最有可能导致他目前的病情？"
  },
  "options": {
    "A": {
      "en": "Amlodipine",
      "zh": "氨氯地平"
    },
    "B": {
      "en": "Diltiazem",
      "zh": "地尔硫卓"
    },
    "C": {
      "en": "Hydrochlorothiazide",
      "zh": "氢氯噻嗪"
    },
    "D": {
      "en": "Lidocaine",
      "zh": "利多卡因"
    },
    "E": {
      "en": "Propranolol",
      "zh": "普萘洛尔"
    },
    "F": {
      "en": "Terazosin",
      "zh": "特拉唑嗪"
    },
    "G": {
      "en": "Valsartan",
      "zh": "缬沙坦"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "This patient's **constipation** and new-onset second-degree **atrioventricular (AV) block** (causing syncope) are likely adverse effects of therapy with a **nondihydropyridine calcium channel blocker (CCB)** (eg, diltiazem, verapamil). These drugs are frequently used to treat hypertension, angina pectoris, and supraventricular arrhythmias, including atrial fibrillation (as in this patient).\n\nNondihydropyridine CCBs exert their primary action by blocking the **L-type calcium channels**, thereby decreasing phase 0 depolarization and conduction velocity in the sinoatrial and AV nodes. This leads to **slowing of the sinus rate** and slowing of conduction through the AV node, which can cause bradycardia and varying degrees of AV block. The drugs also have a **negative inotropic effect** and are relatively contraindicated in patients with left ventricular systolic dysfunction. Constipation, which is typically more prominent with verapamil than diltiazem, likely occurs due to reduced contraction of colonic smooth muscle.\n\n(Choice A) Amlodipine is a dihydropyridine CCB that has a predominant vasodilator effect with minimal negative effect on cardiac conduction and contractility. Major adverse effects include lightheadedness, flushing, and peripheral edema.\n\n(Choice C) Hydrochlorothiazide is a thiazide diuretic used for the treatment of hypertension. It has no role in the management of atrial fibrillation. Adverse effects include hypokalemia and hyponatremia.\n\n(Choice D) Lidocaine is occasionally used in the management of symptomatic ventricular arrhythmias, usually in the setting of acute myocardial infarction. It is not used to treat atrial arrhythmias.\n\n(Choice E) Beta blockers are commonly used for heart rate control in patients with atrial fibrillation and can cause or worsen AV block. However, propranolol is a nonselective beta blocker that impairs bronchodilation and is typically avoided in patients with severe chronic obstructive pulmonary disease. In addition, constipation is not a significant adverse effect of beta blockers.\n\n(Choice F) Terazosin is an alpha-1 adrenergic antagonist used in the treatment of benign prostatic hyperplasia and hypertension. Major adverse effects include lightheadedness and orthostatic hypotension.\n\n(Choice G) Valsartan is an angiotensin II receptor blocker used in the management of hypertension and heart failure with reduced ejection fraction. Common adverse effects include hypotension and hyperkalemia.\n\nEducational objective:\nCommon adverse effects of nondihydropyridine calcium channel blockers (eg, diltiazem, verapamil) include constipation, bradycardia, **atrioventricular block** (negative chronotropic effect), and worsening of heart failure in patients with left ventricular systolic dysfunction (negative inotropic effect).",
    "zh": "该患者的**便秘**和新发二度**房室 (AV) 传导阻滞**（引起晕厥）很可能是使用**非二氢吡啶类钙通道阻滞剂 (CCB)**（例如，地尔硫卓，维拉帕米）治疗的不良反应。 这些药物常用于治疗高血压、心绞痛和室上性心律失常，包括房颤（如该患者）。\n\n非二氢吡啶类 CCB 通过阻断**L 型钙通道**发挥其主要作用，从而降低窦房结和房室结中的 0 相去极化和传导速度。 这会导致**窦性心率减慢**，并通过房室结减缓传导，这可能导致心动过缓和不同程度的房室传导阻滞。 这些药物还具有**负性肌力作用**，并且相对禁用于左心室收缩功能不全的患者。 便秘，通常维拉帕米比地尔硫卓更明显，可能是由于结肠平滑肌收缩减少所致。\n\n（选项 A）氨氯地平是一种二氢吡啶类 CCB，具有主要的血管舒张作用，对心脏传导和收缩力的负面影响最小。 主要不良反应包括头晕、潮红和外周水肿。\n\n（选项 C）氢氯噻嗪是一种噻嗪类利尿剂，用于治疗高血压。 它在房颤的治疗中没有作用。 不良反应包括低钾血症和低钠血症。\n\n（选项 D）利多卡因偶尔用于治疗有症状的室性心律失常，通常在急性心肌梗死的情况下。 它不用来治疗心房心律失常。\n\n（选项 E）β 受体阻滞剂常用于控制房颤患者的心率，并可引起或加重房室传导阻滞。 然而，普萘洛尔是一种非选择性 β 受体阻滞剂，会损害支气管舒张，通常应避免用于患有严重慢性阻塞性肺病的患者。 此外，便秘不是 β 受体阻滞剂的显著不良反应。\n\n（选项 F）特拉唑嗪是一种 α-1 肾上腺素受体拮抗剂，用于治疗良性前列腺增生症和高血压。 主要不良反应包括头晕和体位性低血压。\n\n（选项 G）缬沙坦是一种血管紧张素 II 受体阻滞剂，用于治疗高血压和射血分数降低的心力衰竭。 常见的不良反应包括低血压和高钾血症。\n\n教育目标：\n非二氢吡啶类钙通道阻滞剂（例如，地尔硫卓，维拉帕米）的常见不良反应包括便秘、心动过缓、**房室传导阻滞**（负性变时效应）和左心室收缩功能不全患者心力衰竭恶化（负性肌力效应）。"
  },
  "summary": {
    "en": "This question tests knowledge of the adverse effects of nondihydropyridine calcium channel blockers, specifically diltiazem, and their association with constipation and AV block. It requires understanding the mechanism of action of these drugs and their impact on cardiac conduction.\n\nThe approach to solving this question involves recognizing the patient's symptoms (constipation and AV block) and linking them to the potential side effects of medications used to treat atrial fibrillation and hypertension. Identifying diltiazem as a nondihydropyridine calcium channel blocker is crucial for selecting the correct answer.",
    "zh": "此题考察了对非二氢吡啶类钙通道阻滞剂（特别是地尔硫卓）的不良反应的了解，以及它们与便秘和房室传导阻滞的关系。 它需要了解这些药物的作用机制及其对心脏传导的影响。\n\n解决此题的方法包括识别患者的症状（便秘和房室传导阻滞），并将它们与用于治疗房颤和高血压的药物的潜在副作用联系起来。 确定地尔硫卓为非二氢吡啶类钙通道阻滞剂对于选择正确答案至关重要。"
  },
  "tags": "Atrioventricular block; Calcium channel blockers; Diltiazem; Constipation; Syncope; Cardiology; Pharmacology; Adverse drug effects",
  "category": "CVS",
  "question_id": "153",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\CVS 23\\153",
  "extracted_at": "2025-11-05T11:58:22.528307",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:48:46.811809",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}